168 related articles for article (PubMed ID: 2118273)
1. The role of B cells for in vivo T cell responses to a Friend virus-induced leukemia.
Schultz KR; Klarnet JP; Gieni RS; HayGlass KT; Greenberg PD
Science; 1990 Aug; 249(4971):921-3. PubMed ID: 2118273
[TBL] [Abstract][Full Text] [Related]
2. FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens.
Klarnet JP; Kern DE; Okuno K; Holt C; Lilly F; Greenberg PD
J Exp Med; 1989 Feb; 169(2):457-67. PubMed ID: 2562982
[TBL] [Abstract][Full Text] [Related]
3. Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors.
Chen W; Qin H; Chesebro B; Cheever MA
J Virol; 1996 Nov; 70(11):7773-82. PubMed ID: 8892898
[TBL] [Abstract][Full Text] [Related]
4. Genetic control of T cell responsiveness to the Friend murine leukemia virus envelope antigen. Identification of class II loci of the H-2 as immune response genes.
Miyazawa M; Nishio J; Chesebro B
J Exp Med; 1988 Nov; 168(5):1587-605. PubMed ID: 3141552
[TBL] [Abstract][Full Text] [Related]
5. T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant.
Earl PL; Moss B; Morrison RP; Wehrly K; Nishio J; Chesebro B
Science; 1986 Nov; 234(4777):728-31. PubMed ID: 3490689
[TBL] [Abstract][Full Text] [Related]
6. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
[TBL] [Abstract][Full Text] [Related]
7. Interactions of murine leukemia virus (MuLV) with isolated lymphocytes. II. Infections of B and T cells with Friend virus complex indiffusion chambers and in vitro: effect of polyclonal mitogens.
Cerny J; Hensgen PA; Fistel SH; Demler LM
Int J Cancer; 1976 Aug; 18(2):189-96. PubMed ID: 1085288
[TBL] [Abstract][Full Text] [Related]
8. Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cells.
Kern DE; Klarnet JP; Cheever MA; Greenberg PD
Cancer Res; 1990 Oct; 50(19):6256-63. PubMed ID: 2144789
[TBL] [Abstract][Full Text] [Related]
9. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
Herberman RB; Holden HT; Ting CC; Lavrin DL; Kirchner H
Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223
[TBL] [Abstract][Full Text] [Related]
10. Interactions of murine leukemia virus (MuLV) with isolated lymphocytes. III. Alterations of splenic B and T cells in Friend virus-infected mice.
Cerny J; Essex M; Thomas DB
Int J Cancer; 1976 Aug; 18(2):197-204. PubMed ID: 60287
[TBL] [Abstract][Full Text] [Related]
11. Protection against Friend retrovirus-induced leukemia by recombinant vaccinia viruses expressing the gag gene.
Miyazawa M; Nishio J; Chesebro B
J Virol; 1992 Jul; 66(7):4497-507. PubMed ID: 1534853
[TBL] [Abstract][Full Text] [Related]
12. Different H-2 subregions influence immunization against retrovirus and immunosuppression.
Morrison RP; Earl PL; Nishio J; Lodmell DL; Moss B; Chesebro B
Nature; 1987 Oct 22-28; 329(6141):729-32. PubMed ID: 2823142
[TBL] [Abstract][Full Text] [Related]
13. Impaired generation of anti-AKR/Gross murine leukemia virus cytotoxic T lymphocytes in mice experimentally infected with MuLV.
Coppola MA; Green WR; Rich RF
Viral Immunol; 1996; 9(2):107-19. PubMed ID: 8822627
[TBL] [Abstract][Full Text] [Related]
14. Novel role of CD8(+) T cells and major histocompatibility complex class I genes in the generation of protective CD4(+) Th1 responses during retrovirus infection in mice.
Peterson KE; Stromnes I; Messer R; Hasenkrug K; Chesebro B
J Virol; 2002 Aug; 76(16):7942-8. PubMed ID: 12133998
[TBL] [Abstract][Full Text] [Related]
15. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
Yoshimura A; Shiku H; Nakayama E
J Immunol; 1993 Jun; 150(11):4900-10. PubMed ID: 8496592
[TBL] [Abstract][Full Text] [Related]
16. Multiplicity of virus-encoded helper T-cell epitopes expressed on FBL-3 tumor cells.
Iwashiro M; Kondo T; Shimizu T; Yamagishi H; Takahashi K; Matsubayashi Y; Masuda T; Otaka A; Fujii N; Ishimoto A
J Virol; 1993 Aug; 67(8):4533-42. PubMed ID: 7687300
[TBL] [Abstract][Full Text] [Related]
17. Studies of the mechanisms for the induction of in vivo tumor immunity. I. Induction of primary and secondary cell-mediated cytotoxic responses by adoptive transfer of lymphocytes.
Ting CC
Cell Immunol; 1976 Nov; 27(1):71-81. PubMed ID: 136303
[No Abstract] [Full Text] [Related]
18. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
Wang J; Saffold S; Cao X; Krauss J; Chen W
J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
[TBL] [Abstract][Full Text] [Related]
19. Major histocompatibility complex class I gene controls the generation of gamma interferon-producing CD4(+) and CD8(+) T cells important for recovery from friend retrovirus-induced leukemia.
Peterson KE; Iwashiro M; Hasenkrug KJ; Chesebro B
J Virol; 2000 Jun; 74(11):5363-7. PubMed ID: 10799615
[TBL] [Abstract][Full Text] [Related]
20. The immune response to Moloney murine leukemia virus-induced tumors: induction of cytolytic T lymphocytes specific for both viral and tumor-associated antigens.
Flyer DC; Burakoff SJ; Faller DV
J Immunol; 1986 Dec; 137(12):3968-72. PubMed ID: 3491152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
